Displaying One Session

View
Industry Satellite Symposium Channel 2

Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer

Date
Mon, 07.03.2022
Time
13:00 - 14:00
Room
Channel 2
Chairs
  • Solange Peters (Lausanne, Switzerland)
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer Industry Satellite Symposium

Introduction

Lecture Time
13:00 - 13:10
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer
Room
Channel 2
Date
Mon, 07.03.2022
Time
13:00 - 14:00
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer Industry Satellite Symposium

Round-table discussion (Recent developments in the ADC technology/application; Selection of target antigens; Identification of responders; Overcoming treatment resistance)

Lecture Time
13:10 - 13:45
Speakers
  • Matthias Peipp (Kiel, Germany)
Session Name
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer
Room
Channel 2
Date
Mon, 07.03.2022
Time
13:00 - 14:00
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer Industry Satellite Symposium

Q&A and closing remarks

Lecture Time
13:45 - 14:00
Speakers
  • Solange Peters (Lausanne, Switzerland)
Session Name
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer
Room
Channel 2
Date
Mon, 07.03.2022
Time
13:00 - 14:00